Imovax d.T. Adult Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in Description.
IMOVAX d.T. Adult administration should be postponed during the course of febrile or acute infection processes and in people, who due to a history of exposure, could be in the incubation period of an infection other than the diphtheria or tetanus, which is known, or suspected to be susceptible. However, the presence of a common infection is not a contraindication for vaccination.
IMOVAX d.T. Adult should not be administered to people with a history of thrombocytopenia, hypersensitivity reactions or neurological complications after prior vaccination against tetanus and/or diphtheria.
If there is any contraindication for diphtheria vaccine administration, only the tetanus vaccine should be administered.
When complications, such as allergic reactions and central and/or peripheral nervous system complications are present, consider the vaccination risk against the risk of getting tetanus and diphtheria.
In the cases of wounds in immunocompromised subjects, only the tetanus vaccine should be administered, and it should not be accompanied by the diphtheria component.
In case of wounds, and when there is an absolute contraindication, anti-tetanus immunoglobulin should be administered (2 x 250 IU at four-week intervals).